arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

LifeStance Health Group, Inc.

LFST
$12.09 ▼ -0.47 (-3.74%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
27 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

LifeStance Health Group, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $4.6B
Dividend Yield
Revenue Growth 26.1%
Op. Margin 7.0%
ROIC 1.5%
FCF / Share $0.23
Trailing P/E
Price / Book 3.1x
FCF Yield 1.9%
Debt / Equity 0.19
info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$435.35M
↑ +26.1%
Net Income Profit after all expenses
$23.61M
↑ +65.8%
Operating Margin Operating profit as % of sales
7.0%
↑ +27.5% 33th
FCF / Share Free cash flow per share
$0.23
↑ +297.4%
Long-Term Debt Long-term obligations
$275.50M
↓ -2.6%

Health Breakdown

Profitability
40
Returns
45
Financial Health
67
Cash Quality
98

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters